$AMGN Recent News Apple earnings, Fed vie for investor

New Post Public Reply Private Reply Replies (0) Message Board

Jan 26, 2015 at 12:34 PM

$AMGN Recent News

Apple earnings, Fed vie for investor attention this week 5:54 a.m. Today - Wallace Witkowski
FDA panel recommends approval for first generic biotech drug 4:52 p.m. Jan. 7, 2015 - Wallace Witkowski
Novartis wins FDA staff Ok for Neupogen generic 12:46 p.m. Jan. 5, 2015 - Marta Falconi
Amgen and Kite Pharma in cancer immunotherapy pact 10:01 a.m. Jan. 5, 2015 - Tess Stynes
Cal-Maine Foods shares fall on earnings miss 4:41 p.m. Dec. 23, 2014 - Wallace Witkowski
Amgen boosts first-quarter dividend 30% to 79 cents a share 5:46 p.m. Dec. 17, 2014 - Tom Bemis
Amgen ends trials of stomach-cancer therapy 9:58 a.m. Nov. 24, 2014 - Tess Stynes
Amgen's stock drops after trial misses secondary endpoint 9:20 a.m. Nov. 4, 2014 - Tomi Kilgore
Amgen's stock drops 2% in premarket trade 9:08 a.m. Nov. 4, 2014 - Tomi Kilgore
Amgen study on cancer treatment misses secondary endpoint 9:07 a.m. Nov. 4, 2014 - Tomi Kilgore
Facebook, Gilead shares fall after hours 5:14 p.m. Oct. 28, 2014 - Wallace Witkowski
Amgen, under investor pressure, outlines strategy 9:05 a.m. Oct. 28, 2014 - MarketWatch.com
Amgen's stock rises after company outlines capital allocation plans 8:08 a.m. Oct. 28, 2014 - Tomi Kilgore
Amgen's stock climbs 3.2% in premarket trade after capital allocation plans 7:55 a.m. Oct. 28, 2014 - Tomi Kilgore
Amgen sees 2015 revenue $20.8 bln-$21.3 bln vs. FactSet consensus $20.33 bln 7:54 a.m. Oct. 28, 2014 - Tomi Kilgore
Amgen sees 2015 adj. EPS $9.05-$9.40 vs. FactSet consensus $9.08 7:53 a.m. Oct. 28, 2014 - Tomi Kilgore
Amgen plans to payout 60% of adj. earnings to shareholders through 2018 7:53 a.m. Oct. 28, 2014 - Tomi Kilgore
Amgen plans to raise dividend 30% starting in Q1 2015 7:52 a.m. Oct. 28, 2014 - Tomi Kilgore
Amgen resumes share buybacks, with plans for $2 bln in repurchases through 2015 7:52 a.m. Oct. 28, 2014 - Tomi Kilgore
‘Dumb money’ unloads bullish oil bets as prices pose threat to stocks 7:35 a.m. Oct. 28, 2014 - Shawn Langlois

FDA accepts cholesterol-lowering med BLA under priority review 7:31 a.m. Today - Seeking Alpha
Will Amgen (AMGN) Keep the Earnings Streak Alive in 4Q? - Analyst Blog 6:25 p.m. Jan. 23, 2015 - Zacks.com
Medivation and Astellas Report TERRAIN Data on Xtandi - Analyst Blog 4:20 p.m. Jan. 23, 2015 - Zacks.com
Will Millennials Drive In 2-0-1-5? 3:33 p.m. Jan. 23, 2015 - Seeking Alpha
What Lessons Has Express Scripts Taught Us? The Future For The Pharmaceutical Industry 7:30 a.m. Jan. 23, 2015 - Seeking Alpha
New Guru Jana Partners' Newest Stock Buys 8:05 p.m. Jan. 22, 2015 - GuruFocus.com
UCB's New Epilepsy Drug Under Review in the U.S., EU - Analyst Blog 7:00 p.m. Jan. 22, 2015 - Zacks.com
Curis Up on Immuno-Oncology Agreement with Aurigene - Analyst Blog 6:35 p.m. Jan. 22, 2015 - Zacks.com
2014 Portfolio Review: Year One Of My DGI Journey, Part I 6:29 p.m. Jan. 22, 2015 - Seeking Alpha
BioMarin to Raise Funds to Finance Prosensa Acquisition - Analyst Blog 6:00 p.m. Jan. 22, 2015 - Zacks.com
Novartis' Psoriasis Drug Cosentyx Gets FDA Approval - Analyst Blog 5:40 p.m. Jan. 22, 2015 - Zacks.com
Keryx to Raise $110 Million Through Issuance of Shares - Analyst Blog 4:10 p.m. Jan. 22, 2015 - Zacks.com
Bristol-Myers Makes Leadership Changes, Names New CEO - Analyst Blog 6:13 p.m. Jan. 21, 2015 - Zacks.com
Hospira's Plum 36O Infusion System Gets FDA Clearance - Analyst Blog 6:08 p.m. Jan. 21, 2015 - Zacks.com
Alnylam to Raise $450 Million Through Issuance of Shares - Analyst Blog 5:00 p.m. Jan. 21, 2015 - Zacks.com
Affymetrix Hits 52-Week High on Strong Top-Line Growth - Analyst Blog 12:50 p.m. Jan. 21, 2015 - Zacks.com
Biotech Stock Roundup: EU Approvals for AbbVie & Celgene Drugs, CytRx Partial Clinical Hold Lifted - Analyst Blog 11:02 a.m. Jan. 21, 2015 - Zacks.com
Novartis' Cosentyx Approved in Europe for Plaque Psoriasis - Analyst Blog 6:03 p.m. Jan. 20, 2015 - Zacks.com
Supernus Downgraded as Lead Drugs Face Patent Challenges - Analyst Blog 5:00 p.m. Jan. 20, 2015 - Zacks.com
Sanofi and Boehringer Ingelheim Ink Strategic Deal - Analyst Blog 3:30 p.m. Jan. 20, 2015 - Zacks.com

Critical Alerts For Infinera Corporation, Pandora, Trulia, ResMed and Amgen Released By InvestorsObserver 9:31 a.m. Today - PR Newswire - PRF
Amgen Announces Webcast of 2014 Fourth Quarter and Full Year Financial Results 4:01 p.m. Jan. 22, 2015 - PR Newswire - PRF
Technology Industry Leaders to Join Gala Global, Inc. Board of Directors 8:01 a.m. Jan. 21, 2015 - GlobeNewswire
Global Cancer Biomarkers Market 2015-2019 1:24 p.m. Jan. 20, 2015 - PR Newswire - PRF
Amgen Presents New Data Supporting First-Line Use Of Vectibix® (Panitumumab) In Combination With FOLFOX In Patients With Wild-Type RAS Metastatic Colorectal Cancer 4:01 p.m. Jan. 15, 2015 - PR Newswire - PRF
Global Ankylosing Spondylitis Market 2015-2019 4:16 p.m. Jan. 14, 2015 - PR Newswire - PRF
NantWorks Announces Launch of an Immuno-Oncology Company, NantCell, and Licensing Agreement with Amgen for an Oncology Antibody 8:01 a.m. Jan. 14, 2015 - BusinessWire - BZX
3D Bioprinting Pioneers RBCC and n3D Biosciences Network With Top Biotechnology Investors This Week at Biotech Showcase 2015 in San Francisco 5:00 a.m. Jan. 13, 2015 - BusinessWire - BZX
Amgen and MD Anderson Announce Agreement to Develop BiTE® Therapies for Myelodysplastic Syndrome 4:01 p.m. Jan. 12, 2015 - PR Newswire - PRF
Hospira Submits New Biologics License Application to U.S. FDA for Proposed Epoetin Alfa Biosimilar 9:00 a.m. Jan. 12, 2015 - PR Newswire - PRF
WuXi PharmaTech Acquires NextCODE Health to Create Global Leader in Genomic Medicine 8:00 a.m. Jan. 9, 2015 - PR Newswire - PRF
Amgen To Present At The 33rd Annual J.P. Morgan Healthcare Conference 4:15 p.m. Jan. 8, 2015 - PR Newswire - PRF
Surface Oncology Announces $35 Million Series A Financing to Advance Next-Generation Cancer Immunotherapies 7:30 a.m. Jan. 8, 2015 - BusinessWire - BZX
Global Psoriasis Therapeutics Market 2015-2019 2:12 p.m. Jan. 7, 2015 - PR Newswire - PRF
Amgen and Kite Pharma Announce Strategic Cancer Immunotherapy Collaboration to Advance the Application of Novel Chimeric Antigen Receptor (CAR) T Cell Therapies 9:00 a.m. Jan. 5, 2015 - PR Newswire - PRF
Technical Report on Biotech Stocks -- MannKind, Amgen, Celldex Therapeutics, Juno Therapeutics, and Ironwood Pharma 8:35 a.m. Dec. 31, 2014 - PR Newswire - PRF
Pharmaceuticals, Medicines, Supplements and Drug Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 325400 8:15 a.m. Dec. 23, 2014 - PR Newswire - PRF
Amgen Joins With LabCentral To Support Life-Sciences And Biotech Startups In Cambridge, Massachusetts 9:15 a.m. Dec. 22, 2014 - PR Newswire - PRF
Myriad Genetics Names Bernard Tobin as President of Crescendo Bioscience 7:00 a.m. Dec. 22, 2014 - GlobeNewswire
Amgen Announces 30 Percent Increase In 2015 First Quarter Dividend 5:45 p.m. Dec. 17, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ARTiSTORY's Strategic Advance in Cultural IP Licensing

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Silk Road Maritime Extends Its Global Reach in 2026

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Nocpix Unveils ACE 2 Thermal Riflescope Lineup

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Countries Eye New Investment Paths at CIFIT 2026

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Delhi Pushes Innovation Against Dryland Challenges

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

PathoSearch: A New Era in Pathology With Visual Search

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

IASLC Boosts Global Thoracic Cancer Collaboration

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...